Pancreatic Endocrine Tumor Drug Market
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Pancreatic Endocrine Tumor Drug
1.2 Key Market Segments
1.2.1 Pancreatic Endocrine Tumor Drug Segment by Type
1.2.2 Pancreatic Endocrine Tumor Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Pancreatic Endocrine Tumor Drug Market Overview
2.1 Global Market Overview
2.1.1 Global Pancreatic Endocrine Tumor Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Pancreatic Endocrine Tumor Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Pancreatic Endocrine Tumor Drug Market Competitive Landscape
3.1 Global Pancreatic Endocrine Tumor Drug Sales by Manufacturers (2019-2024)
3.2 Global Pancreatic Endocrine Tumor Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Pancreatic Endocrine Tumor Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pancreatic Endocrine Tumor Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Pancreatic Endocrine Tumor Drug Sales Sites, Area Served, Product Type
3.6 Pancreatic Endocrine Tumor Drug Market Competitive Situation and Trends
3.6.1 Pancreatic Endocrine Tumor Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pancreatic Endocrine Tumor Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Pancreatic Endocrine Tumor Drug Industry Chain Analysis
4.1 Pancreatic Endocrine Tumor Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Pancreatic Endocrine Tumor Drug Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Pancreatic Endocrine Tumor Drug Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pancreatic Endocrine Tumor Drug Sales Market Share by Type (2019-2024)
6.3 Global Pancreatic Endocrine Tumor Drug Market Size Market Share by Type (2019-2024)
6.4 Global Pancreatic Endocrine Tumor Drug Price by Type (2019-2024)
7 Pancreatic Endocrine Tumor Drug Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pancreatic Endocrine Tumor Drug Market Sales by Application (2019-2024)
7.3 Global Pancreatic Endocrine Tumor Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Pancreatic Endocrine Tumor Drug Sales Growth Rate by Application (2019-2024)
8 Pancreatic Endocrine Tumor Drug Market Segmentation by Region
8.1 Global Pancreatic Endocrine Tumor Drug Sales by Region
8.1.1 Global Pancreatic Endocrine Tumor Drug Sales by Region
8.1.2 Global Pancreatic Endocrine Tumor Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Pancreatic Endocrine Tumor Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pancreatic Endocrine Tumor Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pancreatic Endocrine Tumor Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pancreatic Endocrine Tumor Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pancreatic Endocrine Tumor Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Ipsen S.A.
9.1.1 Ipsen S.A. Pancreatic Endocrine Tumor Drug Basic Information
9.1.2 Ipsen S.A. Pancreatic Endocrine Tumor Drug Product Overview
9.1.3 Ipsen S.A. Pancreatic Endocrine Tumor Drug Product Market Performance
9.1.4 Ipsen S.A. Business Overview
9.1.5 Ipsen S.A. Pancreatic Endocrine Tumor Drug SWOT Analysis
9.1.6 Ipsen S.A. Recent Developments
9.2 Jiangsu Hengrui Medicine Co., Ltd.
9.2.1 Jiangsu Hengrui Medicine Co., Ltd. Pancreatic Endocrine Tumor Drug Basic Information
9.2.2 Jiangsu Hengrui Medicine Co., Ltd. Pancreatic Endocrine Tumor Drug Product Overview
9.2.3 Jiangsu Hengrui Medicine Co., Ltd. Pancreatic Endocrine Tumor Drug Product Market Performance
9.2.4 Jiangsu Hengrui Medicine Co., Ltd. Business Overview
9.2.5 Jiangsu Hengrui Medicine Co., Ltd. Pancreatic Endocrine Tumor Drug SWOT Analysis
9.2.6 Jiangsu Hengrui Medicine Co., Ltd. Recent Developments
9.3 MediaPharma s.r.l.
9.3.1 MediaPharma s.r.l. Pancreatic Endocrine Tumor Drug Basic Information
9.3.2 MediaPharma s.r.l. Pancreatic Endocrine Tumor Drug Product Overview
9.3.3 MediaPharma s.r.l. Pancreatic Endocrine Tumor Drug Product Market Performance
9.3.4 MediaPharma s.r.l. Pancreatic Endocrine Tumor Drug SWOT Analysis
9.3.5 MediaPharma s.r.l. Business Overview
9.3.6 MediaPharma s.r.l. Recent Developments
9.4 Novartis AG
9.4.1 Novartis AG Pancreatic Endocrine Tumor Drug Basic Information
9.4.2 Novartis AG Pancreatic Endocrine Tumor Drug Product Overview
9.4.3 Novartis AG Pancreatic Endocrine Tumor Drug Product Market Performance
9.4.4 Novartis AG Business Overview
9.4.5 Novartis AG Recent Developments
9.5 OXiGENE, Inc.
9.5.1 OXiGENE, Inc. Pancreatic Endocrine Tumor Drug Basic Information
9.5.2 OXiGENE, Inc. Pancreatic Endocrine Tumor Drug Product Overview
9.5.3 OXiGENE, Inc. Pancreatic Endocrine Tumor Drug Product Market Performance
9.5.4 OXiGENE, Inc. Business Overview
9.5.5 OXiGENE, Inc. Recent Developments
10 Pancreatic Endocrine Tumor Drug Market Forecast by Region
10.1 Global Pancreatic Endocrine Tumor Drug Market Size Forecast
10.2 Global Pancreatic Endocrine Tumor Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pancreatic Endocrine Tumor Drug Market Size Forecast by Country
10.2.3 Asia Pacific Pancreatic Endocrine Tumor Drug Market Size Forecast by Region
10.2.4 South America Pancreatic Endocrine Tumor Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Pancreatic Endocrine Tumor Drug by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Pancreatic Endocrine Tumor Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Pancreatic Endocrine Tumor Drug by Type (2025-2030)
11.1.2 Global Pancreatic Endocrine Tumor Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Pancreatic Endocrine Tumor Drug by Type (2025-2030)
11.2 Global Pancreatic Endocrine Tumor Drug Market Forecast by Application (2025-2030)
11.2.1 Global Pancreatic Endocrine Tumor Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Pancreatic Endocrine Tumor Drug Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pancreatic Endocrine Tumor Drug Market Size Comparison by Region (M USD)
Table 5. Global Pancreatic Endocrine Tumor Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Pancreatic Endocrine Tumor Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Pancreatic Endocrine Tumor Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Pancreatic Endocrine Tumor Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pancreatic Endocrine Tumor Drug as of 2022)
Table 10. Global Market Pancreatic Endocrine Tumor Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Pancreatic Endocrine Tumor Drug Sales Sites and Area Served
Table 12. Manufacturers Pancreatic Endocrine Tumor Drug Product Type
Table 13. Global Pancreatic Endocrine Tumor Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Pancreatic Endocrine Tumor Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pancreatic Endocrine Tumor Drug Market Challenges
Table 22. Global Pancreatic Endocrine Tumor Drug Sales by Type (Kilotons)
Table 23. Global Pancreatic Endocrine Tumor Drug Market Size by Type (M USD)
Table 24. Global Pancreatic Endocrine Tumor Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global Pancreatic Endocrine Tumor Drug Sales Market Share by Type (2019-2024)
Table 26. Global Pancreatic Endocrine Tumor Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Pancreatic Endocrine Tumor Drug Market Size Share by Type (2019-2024)
Table 28. Global Pancreatic Endocrine Tumor Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global Pancreatic Endocrine Tumor Drug Sales (Kilotons) by Application
Table 30. Global Pancreatic Endocrine Tumor Drug Market Size by Application
Table 31. Global Pancreatic Endocrine Tumor Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Pancreatic Endocrine Tumor Drug Sales Market Share by Application (2019-2024)
Table 33. Global Pancreatic Endocrine Tumor Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Pancreatic Endocrine Tumor Drug Market Share by Application (2019-2024)
Table 35. Global Pancreatic Endocrine Tumor Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Pancreatic Endocrine Tumor Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Pancreatic Endocrine Tumor Drug Sales Market Share by Region (2019-2024)
Table 38. North America Pancreatic Endocrine Tumor Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Pancreatic Endocrine Tumor Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Pancreatic Endocrine Tumor Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Pancreatic Endocrine Tumor Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Pancreatic Endocrine Tumor Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. Ipsen S.A. Pancreatic Endocrine Tumor Drug Basic Information
Table 44. Ipsen S.A. Pancreatic Endocrine Tumor Drug Product Overview
Table 45. Ipsen S.A. Pancreatic Endocrine Tumor Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Ipsen S.A. Business Overview
Table 47. Ipsen S.A. Pancreatic Endocrine Tumor Drug SWOT Analysis
Table 48. Ipsen S.A. Recent Developments
Table 49. Jiangsu Hengrui Medicine Co., Ltd. Pancreatic Endocrine Tumor Drug Basic Information
Table 50. Jiangsu Hengrui Medicine Co., Ltd. Pancreatic Endocrine Tumor Drug Product Overview
Table 51. Jiangsu Hengrui Medicine Co., Ltd. Pancreatic Endocrine Tumor Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Jiangsu Hengrui Medicine Co., Ltd. Business Overview
Table 53. Jiangsu Hengrui Medicine Co., Ltd. Pancreatic Endocrine Tumor Drug SWOT Analysis
Table 54. Jiangsu Hengrui Medicine Co., Ltd. Recent Developments
Table 55. MediaPharma s.r.l. Pancreatic Endocrine Tumor Drug Basic Information
Table 56. MediaPharma s.r.l. Pancreatic Endocrine Tumor Drug Product Overview
Table 57. MediaPharma s.r.l. Pancreatic Endocrine Tumor Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. MediaPharma s.r.l. Pancreatic Endocrine Tumor Drug SWOT Analysis
Table 59. MediaPharma s.r.l. Business Overview
Table 60. MediaPharma s.r.l. Recent Developments
Table 61. Novartis AG Pancreatic Endocrine Tumor Drug Basic Information
Table 62. Novartis AG Pancreatic Endocrine Tumor Drug Product Overview
Table 63. Novartis AG Pancreatic Endocrine Tumor Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Novartis AG Business Overview
Table 65. Novartis AG Recent Developments
Table 66. OXiGENE, Inc. Pancreatic Endocrine Tumor Drug Basic Information
Table 67. OXiGENE, Inc. Pancreatic Endocrine Tumor Drug Product Overview
Table 68. OXiGENE, Inc. Pancreatic Endocrine Tumor Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. OXiGENE, Inc. Business Overview
Table 70. OXiGENE, Inc. Recent Developments
Table 71. Global Pancreatic Endocrine Tumor Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 72. Global Pancreatic Endocrine Tumor Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 73. North America Pancreatic Endocrine Tumor Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 74. North America Pancreatic Endocrine Tumor Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 75. Europe Pancreatic Endocrine Tumor Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 76. Europe Pancreatic Endocrine Tumor Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 77. Asia Pacific Pancreatic Endocrine Tumor Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 78. Asia Pacific Pancreatic Endocrine Tumor Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 79. South America Pancreatic Endocrine Tumor Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 80. South America Pancreatic Endocrine Tumor Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 81. Middle East and Africa Pancreatic Endocrine Tumor Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 82. Middle East and Africa Pancreatic Endocrine Tumor Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 83. Global Pancreatic Endocrine Tumor Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 84. Global Pancreatic Endocrine Tumor Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 85. Global Pancreatic Endocrine Tumor Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 86. Global Pancreatic Endocrine Tumor Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 87. Global Pancreatic Endocrine Tumor Drug Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Pancreatic Endocrine Tumor Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pancreatic Endocrine Tumor Drug Market Size (M USD), 2019-2030
Figure 5. Global Pancreatic Endocrine Tumor Drug Market Size (M USD) (2019-2030)
Figure 6. Global Pancreatic Endocrine Tumor Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pancreatic Endocrine Tumor Drug Market Size by Country (M USD)
Figure 11. Pancreatic Endocrine Tumor Drug Sales Share by Manufacturers in 2023
Figure 12. Global Pancreatic Endocrine Tumor Drug Revenue Share by Manufacturers in 2023
Figure 13. Pancreatic Endocrine Tumor Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Pancreatic Endocrine Tumor Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Pancreatic Endocrine Tumor Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Pancreatic Endocrine Tumor Drug Market Share by Type
Figure 18. Sales Market Share of Pancreatic Endocrine Tumor Drug by Type (2019-2024)
Figure 19. Sales Market Share of Pancreatic Endocrine Tumor Drug by Type in 2023
Figure 20. Market Size Share of Pancreatic Endocrine Tumor Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Pancreatic Endocrine Tumor Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Pancreatic Endocrine Tumor Drug Market Share by Application
Figure 24. Global Pancreatic Endocrine Tumor Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Pancreatic Endocrine Tumor Drug Sales Market Share by Application in 2023
Figure 26. Global Pancreatic Endocrine Tumor Drug Market Share by Application (2019-2024)
Figure 27. Global Pancreatic Endocrine Tumor Drug Market Share by Application in 2023
Figure 28. Global Pancreatic Endocrine Tumor Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Pancreatic Endocrine Tumor Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Pancreatic Endocrine Tumor Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Pancreatic Endocrine Tumor Drug Sales Market Share by Country in 2023
Figure 32. U.S. Pancreatic Endocrine Tumor Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Pancreatic Endocrine Tumor Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Pancreatic Endocrine Tumor Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Pancreatic Endocrine Tumor Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Pancreatic Endocrine Tumor Drug Sales Market Share by Country in 2023
Figure 37. Germany Pancreatic Endocrine Tumor Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Pancreatic Endocrine Tumor Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Pancreatic Endocrine Tumor Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Pancreatic Endocrine Tumor Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Pancreatic Endocrine Tumor Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Pancreatic Endocrine Tumor Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Pancreatic Endocrine Tumor Drug Sales Market Share by Region in 2023
Figure 44. China Pancreatic Endocrine Tumor Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Pancreatic Endocrine Tumor Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Pancreatic Endocrine Tumor Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Pancreatic Endocrine Tumor Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Pancreatic Endocrine Tumor Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Pancreatic Endocrine Tumor Drug Sales and Growth Rate (Kilotons)
Figure 50. South America Pancreatic Endocrine Tumor Drug Sales Market Share by Country in 2023
Figure 51. Brazil Pancreatic Endocrine Tumor Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Pancreatic Endocrine Tumor Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Pancreatic Endocrine Tumor Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Pancreatic Endocrine Tumor Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Pancreatic Endocrine Tumor Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Pancreatic Endocrine Tumor Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Pancreatic Endocrine Tumor Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Pancreatic Endocrine Tumor Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Pancreatic Endocrine Tumor Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Pancreatic Endocrine Tumor Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Pancreatic Endocrine Tumor Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Pancreatic Endocrine Tumor Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Pancreatic Endocrine Tumor Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Pancreatic Endocrine Tumor Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Pancreatic Endocrine Tumor Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Pancreatic Endocrine Tumor Drug Market Share Forecast by Application (2025-2030)
Industry Market Size
